Tinker, Am I mistaken? If a clinical trial was required for generic copaxone, wouldn't the FDA just be looking for safety profile. If so, wouldn't they be able to show safety with a smaller group in a year or so? TIA -Paul
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.